A challenge procedure based on reflux of Ureaplasma urealyticum to the rat kidney was used to examine the disease-causing potential of this species for the upper urinary tract. Renal infection was detected 8 days after challenge in 90 to 100% of animals exposed to 107 ureaplasmas but was not detected in animals exposed to fewer than 106 microorganisms. Viable microorganisms were recoverable from more than 60% of infected animals throughout a 24-week follow-up period of study. Animals with persistent infection exhibited a humoral response involving immunoglobulin M and immunoglobulin G antibody. These results show that U. urealyticum is capable of giving rise to chronic infection in the kidneys of rats following challenge via the ascending route.
Ureaplasma urealyticilm has been recovered from urine aspirated from the bladder and renal parenchyma of patients with reflux nephropathy and declining renal function (1) . This fastidious microorganism is the most prevalent mycoplasma in the human genital tract and has been associated with a wide range of genitourinary disorders (1) . However, U. utrealyticim has been isolated from the upper urinary tract in only a few studies (1, 11, 12) , and its etiologic significance in renal disease is unknown. Therefore, a study was undertaken to examine the disease-causing potential of these bacteria in the upper urinary tract. The ascending route of infection in rats was used to document bacteriologic, immunologic, and histologic features of the hostparasite interaction. The present report describes the bacteriologic and serologic findings.
MATERIALS AND METHODS
Challenge microorganism. A strain of U. itrealyticlum isolated from the upper urinary tract of a patient with proven renal disease was used. The strain was derived from a single colony isolate and was characterized as serovar VIII (7) by using a colony immunofluorescence method (3) . The isolate was cultivated in ureaplasma broth, and a 16-h culture was stored in 1-ml aliquots at -70°C. For use, an ampoule was thawed and the organism was seeded into ureaplasma broth and incubated at 36°C until the color changed (16 to 20 h).
Ureaplasma identification. Isolates were identified on the basis of colony size and morphology, oxidation of manganese salts by ammonium ions, and urease production.
Experimental animals. Virgin female Hooded-Wistar rats weighing 200 to 220 g were used. The experimental strain is propagated by random breeding in a closed, mycoplasmafree colony. Unchallenged animals, selected at random, were screened for U. urealyticum by culturing voided urine and vaginal mucus. Animals were then killed, and homogenates of bladder and kidneys were cultured for ureaplasmas and other bacteria. U. urealyticum was not recovered in broth or on agar culture medium from any sample. During experiments, animals were housed in groups of five in plastic cages in an air-conditioned (21°C) animal holding room. Animals were supplied with food (Barastoc Mouse Breeder Ration Cubes) and water ad libitum unless otherwise stated. * Corresponding author.
Culture media. All culture media were prepared with deionized water and AnalaR grade reagents.
Horse blood agar. Defibrinated horse blood (4%) was incorporated into Columbia agar to which were added vitamin K (0.5 pLg/ml) and hemin (5 mg/liter).
Ureaplasma agar. Ureaplasma basal agar medium A7 (40 g/liter) (GIBCO) was adjusted to pH 5.5 with 1 N HCl and autoclaved at 121°C for 10 min. On cooling to 60°C, the following substances were added: 20% horse serum (not inactivated; Commonwealth Serum Laboratories [CSL]), 0.5% CVA enrichment (GIBCO), 0.25% yeast extract (GIBCO), 0.1% urea, 0.002% phenol red, 0.01% L-cysteine hydrochloride, ampicillin (40 ,ug/ml), flucloxacillin (20 ,ug/ ml), and carbenicillin (500 ,ug/ml).
Ureaplasma broth. Spirolate broth (15 g/liter) (BBL)-NaCl (5 g/liter)-KH2PO4 (0.2 g/liter) was adjusted to pH 6.0 with 1 N HCI and autoclaved at 121°C for 10 min. On cooling to 60°C, the following substances were added: 4% horse serum (not inactivated), 0.05% urea, 0.002% phenol red, glycyl-L-histidyl-L-lysine acetate monohydrate (0.02 jig/ml) (Calbiochem-Behring), ampicillin (40 p.g/ml), and flucloxacillin (20 ,ug/ml).
ELISA antigen. For enzyme-linked immunosorbent assay (ELISA) antigen, media were prepared as described above, except that the basal medium contained 21 g of PPLO broth per liter without crystal violet (Difco) instead of spirolate broth, and fetal bovine serum was substituted for horse serum.
Challenge procedures. All challenge procedures were performed under aseptic conditions by using light ether anesthesia without premedication. A midline incision was used in laparotomies. Abdominal muscle was sutured with 000 catgut, and the skin was sutured with 00 silk. Animals challenged with sterile broth medium were included in all experiments as controls.
Direct challenge. For direct challenge, the left kidney was exposed by a midline incision and 0.02 ml of challenge suspension (2,000 CFU) was injected into the renal parenchyma by using a 30-gauge needle. Ascending challenge. For ascending challenge, 1-ml volumes of ureaplasma suspension were introduced into the bladder, while the external meatus was closed with a forceps by using 2-ml Luer syringes and 23-gauge needles that had been modified by grinding the tips to give round, smooth 1236 PICKERING AND BIRCH openings. After instillation of bacteria, the needle was withdrawn and the bladder was lightly massaged through the abdominal wall. Immediately after challenge, animals were given an intramuscular dose of 40 mg of ampicillin. Food and water were withheld from animals for 16 h prior to challenge and for 8 h after challenge.
Intravenous challenge. For intravenous challenge, a tail vein was heated with warm running water, and a tourniquet was fastened at the base of the tail. A 25-gauge butterfly needle was inserted into a vein, and the tourniquet was removed. One milliliter for challenge inoculum (107 CFU) was then injected.
Hyperimmunization of rats. Hyperimmune serum was produced by using a modification of the method of Shepard and Lunceford (10) . One liter of 18-h broth culture was centrifuged at 40,000 x g for 20 min at 4°C in a Sorvall RC-5B centrifuge. The pellet was washed twice in phosphatebuffered saline (PBS) (pH 7.4) and resuspended in 20 ml of PBS (10Ox concentrate). This suspension was diluted in PBS to yield a transmittance of 50% of 450 nm and stored at -20°C. After a preimmunization bleed, animals were challenged as follows. Antigen suspensions (2 ml) were mixed with 2 ml of Freund adjuvant, and 1 ml was injected in divided doses into the nape of the neck, rump, and peritoneal cavity. Three days later, 0.5 ml of antigen (without adjuvant) was given intravenously. Over the following 9 days, doses of 1 ml (1 day), 1.5 ml (2 days), and 2 ml (3 days) were administered intravenously. Animals were exsanguinated on day 25.
Survival of ureaplasmas in rat urine. A 0.25-ml portion of an 18-h broth culture containing 2 x 107 CFU/ml was added to 9.75 ml of pooled, filter-sterilized rat urine and placed in a water bath at 37°C. Duplicate 0.02-ml samples of urine and 10-2 dilutions of urine in saline were plated on ureaplasma agar at intervals. Kidney culture. Kidneys were washed in 30 ml of sterile saline. The renal capsule and ureter were dissected away, and the kidneys were ground in all-glass tissue grinders with a small volume of antibiotic-free ureaplasma broth. The suspension was made up to 5 ml with sterile broth. Onetenth-milliliter volumes of suspension and 10-2 saline dilution were plated on ureaplasma agar and blood agar for colony counts of aerobic and anaerobic bacteria.
Blood culture. A 0.1-ml amount of blood, collected from a tail vein, was seeded into 5 ml of ureaplasma broth, which was incubated for up to 1 week.
Solid-phase enzyme immunoassay. Dynatech Immunolon M129A microdilution plates with flat-bottomed wells were used for solid-phase enzyme immunoassay. Antisera and conjugate. Goat anti-rat immunoglobulin G (IgG), IgM, and IgA (Nordic Immunological Laboratories) and peroxidase-labeled rabbit anti-goat IgG (Organon Teknika) were used as antisera and conjugate.
Antigen preparation. One liter of broth was seeded with 10 ml of an 18-h ureaplasma culture and incubated at 36°C until the color changed. Ureaplasmas were harvested by centrifugation at 40,000 x g for 20 min at 4°C in a Sorvall RC-5B centrifuge. The pellet was washed twice in 0.1 M PBS (pH 7.4) and finally suspended in 10 ml of PBS (100x concentrate). Control antigen was prepared similarly, by using sterile broth medium. Protein concentrations in antigen suspensions were determined by the method of Lowry et al. (5) . These concentrations were 3.1 mg/liter for ureaplasma pellets and 3.0 mg/liter for control pellets. Suspensions were stored in 1-ml aliquots at -70°C.
Antigen titration. Dilutions of antigen concentrate were (Fig. 1) . In these tests, maximum A490 readings were obtained with antigen that had been concentrated fourfold. Several broth components were assayed with serum from hyperimmunized animals and with prechallenge serum (Fig. 2) . The hyperimmune serum showed activity with horse serum antigen (Amax = 1.12) and spirolate broth (Amax = 0.34). Negligible activity occurred with other medium components. The prechallenge serum was uniformly unreactive. Assay endpoint. The endpoint for serum titrations was assessed as the midpoint between maximum and base-line absorbances. This calculation, using the hyperimmune serum, is illustrated in Fig. 3 . Absorbances exceeded 1.40 for dilutions in the range 210 to 2-20 but fell to 0.20 over dilutions in the range 2-20 to 2-25. The endpoint was determined as the midpoint between 1.40 and 0.20 (i.e., 0.80). Absorbances higher than 0.80 were deemed positive. Whereas this system may have produced some false-negative results, the number of false-positive findings would have been minimized in an assay system with a consistent background absorbance of 0.20 to 0.60.
RESULTS
Survival of ureaplasmas in rat urine. Prior to conducting challenge experiments, the ability of U. urealyticum to survive exposure to pooled rat urine at 37°C was assessed. Viable counts declined from 3.8 x 106 CFU/ml to 1.0 x 106 CFU/ml during 4 h of exposure.
Survival in rat kidneys. Ten animals were challenged with 2,000 CFU of the challenge strain by direct inoculation into both kidneys. Of 10 animals killed 24 h after challenge, 6 showed a 2.4-to 25-fold increase in the numbers of ureaplas- (Fig. 4) , and seven of these animals had bilateral persistence. In contrast, only 2 of 10 animals receiving 106 bacteria and 0 of 30 receiving <106 bacteria harbored these bacteria in their kidneys at the 8-day time point.
Persistence of ureaplasmas in the kidney. Eighty rats were reflux challenged, and at intervals over 52 weeks animals were killed and their kidneys were removed for culture. Ureaplasmas were recovered from more than 80% of animals during the first 4 months of the study (Table 3) . At from 5 min to 3 days after reflux. All samples were culture negative.
Cultures of renal tissue homogenate from 15 animals challenged with 107 ureaplasmas via a tail vein and from 5 hyperimmunized animals challenged with 107 ureaplasmas via the ascending route were ureaplasma-free 4 weeks after challenge.
Rechallenge with isolates from three rats. Isolates from three rats were serotyped and cultured in ureaplasma broth, and culture suspensions were used to challenge 15 uninfected animals. Each of the isolates was confirmed to be of serovar VIII. Animals were killed 8 days after challenge, and their kidneys were cultured as described above. All animals yielded positive cultures from one or both kidneys that were also of serotype VIII.
Antibody response. Reflux challenge-live bacteria. In the group of animals that were culture positive at autopsy, IgM antibody was detectable 1 week after challenge. Titers peaked at 4 weeks postchallenge before stabilizing at a lower value for the remainder of the test period (Fig. 5) . IgG was detectable at 2 weeks post challenge and peaked at 9 weeks before declining slightly. IgA antibody was not detected in the serum of any animal. The antibody responses of 18 rats that were culture negative at autopsy are listed in Fig. 6 . IgG was detectable 2 weeks after challenge. Titers reached a peak at 3 weeks before declining, and antibody was not detectable after 7 weeks. Similarly, IgM antibody was only detectable 1 to 5 weeks after challenge. IgA antibody was not detectable in the serum of any animal.
Reflux challenge-sterile broth medium. Antibody was not had infection in one or both kidneys 8 days after challenge, whereas animals receiving fewer than 106 bacteria were culture negative at the same time point. In apparent contrast with this ability to resist infection, we found that infected animals harbored ureaplasmas in the kidney for prolonged periods. This is in accord with the findings in patients who have been shown to yield the same ureaplasma serovar from urine aspirated from the bladder for more than 12 months (3).
A further similarity between the experimental and human infections relates to the small numbers of ureaplasmas present in the urinary tract. Most infected patients yield only 104 ureaplasmas per ml from urine aspirated from the bladder; most rats yielded fewer than 104 ureaplasmas per kidney in this study. Lysolecithin from animal tissue is a known inhibitor of mycoplasmas, including ureaplasmas (6). To minimize this inhibitory effect in the present study, cultures were established immediately after homogenization of kidneys. Nevertheless, it is possible that the brief exposure to lysolecithin during tissue processing affected ureaplasma viability. Alternatively, release of this inhibitory substance from damaged cells in the upper urinary tract might have maintained viable counts in damaged tissue at a low level. There was good evidence, however, of bacterial multiplication within the kidney during the immediate postchallenge period. Ureaplasmas were also capable of surviving in rat urine; more than 75% of cells remained viable after exposure for 4 h. It was interesting to note that the bacteria did not multiply in the urine during that time. Several factors are known to limit growth of ureaplasmas in broth culture, including a pH greater than 7 (2, 9), osmotic pressure above 600 mOsm/kg (4, 8) , and high ammonium ion concentrations (2, 8) . It is possible that one or more of these factors might inhibit multiplication in the urine also.
The finding that ureaplasmas were present in the kidneys or infected animals for several months led to an investigation of the humoral response. Several methods have been used to assay antibodies to these bacteria. An enzyme immunoassay was preferred in the present study since live antigen is not required, as it is in the metabolic inhibition and bactericidal assays. In addition, ELISAs enable individual antibody classes to be assayed. The crucial step in developing an ELISA for ureaplasmas relates to the preparation of the antigen (13, 14) . We found that pellets obtained by centrifugation of broth cultures and sterile medium contained similar amounts of protein, suggesting that the major components were medium constituents. The study used unwashed broth suspensions for challenge, and consequently, animals synthesized antibody to some of these medium components. It was therefore necessary to substitute other serum and peptones in the medium used for antigen preparation. The addition of fetal bovine serum instead of horse serum and PPLO broth base instead of spirolate broth reduced the background activity of hyperimmune serum by 75%. By using this assay, a humoral response was detectable for up to 24 weeks after a single reflux challenge. Antibody was not detected in the sera of unchallenged animals or of animals challenged with sterile broth medium. IgM antibody was detectable at 1 week postchallenge, and IgG antibody appeared 1 week later. IgA antibody was not detected in the circulation at any time point.
Animals with prolonged infection exhibited the strongest response. In these animals, IgM titers peaked at 4 weeks and IgG titers were highest at 9 weeks. After these time points, antibody titers declined slightly and stabilized at the lower levels for the remainder of the study period. In contrast, animals with self-limiting infection exhibited a transient response and antibody was not detectable in the serum later than 8 weeks postchallenge. A similar transient response occurred in animals challenged with a 120-h culture (i.e., late decline phase, when few viable cells remained). These findings suggest that persistence of circulating antibody is good evidence of active infection in this experimental system. Antibody titers did not correspond with the colony counts from kidney tissue. Furthermore, titers showed little variation among infected animals. There was not more than a twofold difference in titers between samples at any one time point. The findings of this study show clearly that U. urealyticum cultured from the human urinary tract is capable of persisting in the rat kidney after a single reflux challenge. During this period, animals generated an antibody response. Challenge bacteria could be isolated from infected kidney tissue, and when introduced into additional animals, the isolates gave rise to the same pattern of infection.
